Страница 1 из 1

Аспирин и риск кровотечений при вторичной профилактике

Добавлено: Пт сен 08, 2017 1:13 am
Pyankov Vasily
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study

In patients receiving aspirin-based antiplatelet treatment without routine PPI use, the long-term risk of major bleeding is higher and more sustained in older patients in practice than in the younger patients in previous trials, with a substantial risk of disabling or fatal upper gastrointestinal bleeding. Given that half of the major bleeds in patients aged 75 years or older were upper gastrointestinal, the estimated NNT for routine PPI use to prevent such bleeds is low, and co-prescription should be encouraged.

http://www.thelancet.com/pdfs/journals/ ... 0770-5.pdf